What Factors Propelled The Growth Of The Parenteral Nutrition Market In The Past?
The parenteral nutrition market has seen considerable growth due to a variety of factors.
• The market size for parenteral nutrition has seen substantial growth in the past few years. From 2024 to 2025, the market will expand from $6.77 billion to $7.16 billion, with a compound annual growth rate (CAGR) of 5.7%.
Factors such as increased disposable income and urbanization, a rising number of obese people, and the growing preference for noninvasive and minimally invasive aesthetic procedures have contributed to the growth during the historic period.
What Is The Projected Growth And Market Size For The Parenteral Nutrition
The parenteral nutrition market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, substantial growth is predicted in the parenteral nutrition market. It's estimated to escalate to $9.21 billion by 2029, marking a compound annual growth rate (CAGR) of 6.5%.
Factors such as an aging population, swift urbanization, a boost in disposable income, and a rise in mergers and acquisitions contribute to this growth in the forecasted period. Furthermore, some of the primary trends for the predicted period include advancements in products, the application of AI in aesthetics, progress in focal radio frequency technology, the usage of laser-assisted liposuction, and an uptick in partnerships and collaborations.
What Main Forces Are Fueling Expansion In The Parenteral Nutrition Market?
The escalating incidence of malnutrition worldwide is propelling the expansion of the parenteral nutrition market. Malnutrition embodies deficiencies, surpluses, or imbalances in an individual's nutrient or energy consumption. The rise in premature births, leading to immune system dysfunction and insufficient nutrition, has heightened the need for and application of parenteral nutrition in infants and children. For instance, according to the United Nations International Children's Emergency Fund, a US-based entity, in May 2023, nearly half of all under-five children's deaths are linked to undernutrition. Undernutrition not only elevates the risk of death from common infections in children but also augments the frequency and intensity of such infections and prolongs recovery. Therefore, the escalating incidence of malnutrition worldwide is anticipated to stimulate the demand for parenteral nutrition during the forecasting period.
What Are The Main Segments Of The Global Parenteral Nutrition Market?
The parenteral nutrition market covered in this report is segmented –
1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions
2) By Consumer Type: Children and New-born, Adults
3) By End-User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Amino Acids: Essential Amino Acids, Non-Essential Amino Acids, Specialized Amino Acid Solutions
2) By Fats: Lipid Emulsions (Soybean Oil, Olive Oil, etc.), Fish Oil-Based Lipid Emulsions, Medium-Chain Triglycerides (MCTs)
3) By Carbohydrates: Dextrose Solutions, Maltodextrin, Fructose
4) By Trace Elements: Zinc, Copper, Selenium, Manganese
5) By Vitamins: Water-Soluble Vitamins (B-complex, Vitamin C), Fat-Soluble Vitamins (A, D, E, K)
6) By Minerals: Electrolytes (Sodium, Potassium, Calcium, Magnesium), Phosphorus
7) By Other Compositions: Antioxidants, Additives, Specialty Nutrients
Pre-Book The Parenteral Nutrition Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Parenteral Nutrition Market?
In the parental nutrition market, a significant trend is product innovation. Companies within this market are diversifying their parenteral nutrition offerings by introducing groundbreaking products such as the four-oil lipid injectable emulsion. For instance, Fresenius Kabi, a pharmaceutical company based in Germany, was granted approval by the United States Food and Drug Administration (US FDA) to release their SMOFlipid lipid injectable emulsion. This approval, granted in March 2022, allows the product to be used for pediatric parenteral nutrition, encompassing both term and preterm neonates. The SMOFlipid lipid injectable emulsion has the distinction of being the only four-oil lipid injectable emulsion available, consisting of soybean oil, medium-chain triglycerides, olive oil, and fish oil - an excellent source of omega-3 fatty acids. Its application ranges from hospital use right through to home care settings.
Who Are the Key Players in the Parenteral Nutrition Market?
Major companies operating in the parenteral nutrition market include:
• Fresenius Kabi
• Baxter International Inc.
• B. Braun Melsungen AG
• ICU Medical. Inc.
• Grifols
• S.A.
• Otsuka Pharmaceutical Co. Ltd.
• Claris Lifesciences Limited
• Sichuan Kelun Pharmaceutical Co. Ltd.
• JW Pharmaceuticals
• Meiji Holdings Co. Ltd.
• Aculife Healthcare Pvt. Ltd.
• Aspen Pharmacare
• Fresenius SE & Co. KGaA
• Ajinomoto Co.. Inc.
• Braun Medical Inc.
• Laboratoires Aguettant
• AnazaoHealth Corporation
• Baxter Healthcare Corporation
• BioScrip. Inc.
• Sichuan Pharmaceutical Co.
• United Pharmaceuticals
• HOPES Pharmaceuticals
• Braun Medical Ltd
• Calea UK
What Is The Most Dominant Region In The Parenteral Nutrition Market?
North America was the largest region in the parenteral nutrition market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
